Neuro-Oncology Reviews

Volume 25 Number 7
15 April 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 7, 15 April

Rahman R, Polley MC, Alder L, Brastianos PK, Anders CK, Tawbi HA, Mehta M, Wen PY, Geyer S, de Groot J, Zadeh G, Piantadosi S, Galanis E, Khasraw M.
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.
Lancet Oncol. 2023 Apr;24(4):e161-e171
. doi: 10.1016/S1470-2045(23)00005-0. PMID: 36990614. Meeting report˰ ˍ

Cocito C, Martin B, Giantini-Larsen AM, Valcarce-Aspegren M, Souweidane MM, Szalontay L, Dahmane N, Greenfield JP.
Leptomeningeal dissemination in pediatric brain tumors.
Neoplasia. 2023 Apr 1;39:100898
. doi: 10.1016/j.neo.2023.100898. PMID: 37011459. Review. ˍ

Otani Y, Satomi K, Suruga Y, Ishida J, Fujii K, Ichimura K, Date I.
Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas.
Brain Tumor Pathol. 2023 Apr 1. doi: 10.1007/s10014-023-00457-6. PMID: 37004583. Review˰ ˍ


Yalamarty SSK, Filipczak N, Li X, Subhan MA, Parveen F, Ataide JA, Rajmalani BA, Torchilin VP.
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM).
Cancers (Basel). 2023 Apr 1;15(7):2116. doi: 10.3390/cancers15072116. PMID: 37046777. Review. ˍ

Neth BJ, Webb MJ, Parney IF, Sener UT.
The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma.
Pharmaceutics. 2023 Apr 3;15(4):1134. doi: 10.3390/pharmaceutics15041134. PMID: 37111620. Review. ˍ

Alimonti P, Gonzalez Castro LN.
The Current Landscape of Immune Checkpoint Inhibitor Immunotherapy for Primary and Metastatic Brain Tumors.
Antibodies (Basel). 2023 Apr 4;12(2):27. doi: 10.3390/antib12020027. PMID: 37092448. Review. ˍ

Hossain R, Ibrahim RB, Hashim HB.
Automated brain tumor detection using machine learning: A bibliometric review.
World Neurosurg. 2023 Apr 4
;S1878-8750(23)00440-0. doi: 10.1016/j.wneu.2023.03.115. PMID: 37019303. Bibliometric analysis˰ ˍ

Chartouni A, Mouawad A, Boutros M, Attieh F, Medawar N, Kourie HR.
Mesenchymal stem cells: a trojan horse to treat glioblastoma.
Invest New Drugs. 2023 Apr 5. doi: 10.1007/s10637-023-01352-9. PMID: 37017885. Review˰ ˍ

Bailleul J, Vlashi E.
Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance.
Antioxid Redox Signal. 2023 Apr 5. doi: 10.1089/ars.2022.0088. PMID: 37022791. Review˰ ˍ

McKevitt FM.
What neurologists can do for neuro-oncology patients.
Pract Neurol. 2023 Apr 5:pn-2022-003665
. doi: 10.1136/pn-2022-003665. PMID: 37019612. Review˰ ˍ

Wu SQ, Liu Y, Zhou J, You YT, Zhou XH, Chen LQ, Kwan HY, Zhao XS, Wu YF, Liu YY.
Research trends and prospects on brain metastasis from breast cancer: A bibliometric analysis.
Front Oncol. 2023 Apr 5;13:1091249. doi: 10.3389/fonc.2023.1091249. PMID: 37091185. Bibliometric analysis. ˍ


Agrawal M, Mishra S, Garg K, Ranjan M, Kasper E, Rezai A, Agrawal D, Singh M, Kale SS.
Trends in Stereotactic Radiosurgery for Intracranial and Spinal Pathologies: Analysis of the Top 100 Most Cited Articles.
Neurol India. 2023 Apr 6;71(Supplement):S39-S48. doi: 10.4103/0028-3886.373651? PMID: 37026333. Bibliometric analysis. ˍ

Akimoto J.
An enduring debate on gliomatosis cerebri.
Brain Tumor Pathol. 2023 Apr 6
. doi: 10.1007/s10014-023-00454-9. PMID: 37022648. Review˰ ˍ

Garg K, Agrawal D.
Role of Stereotactic Radiosurgery in Glial Tumors.
Neurol India. 2023 Apr 6;71(Supplement):S207-S214. doi: 10.4103/0028-3886.373633? PMID: 37026354. Review. ˍ

Grand S, Nedunchelian M, Charara S, Demaison R, Jean C, Galloux A, Kastler A, Attye A, Berthet C, Krainik A.
Tumor or not a tumor: Pitfalls and differential diagnosis in neuro-oncology.
Rev Neurol (Paris). 2023 Apr 6:S0035-3787(23)00893-7. doi: 10.1016/j.neurol.2023.03.011. PMID: 37030987. Review˰ ˍ

Noon A, Galban S.
Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas.
Neoplasia. 2023 Apr 6;40:100899. doi: 10.1016/j.neo.2023.100899. PMID: 37030112. Review. ˍ

Sahrizan NSA, Manan HA, Abdul Hamid H, Abdullah JM, Yahya N.
Functional Alteration in the Brain Due to Tumour Invasion in Paediatric Patients: A Systematic Review.
Cancers (Basel). 2023 Apr 6;15(7):2168. doi: 10.3390/cancers15072168. PMID: 37046828. Review. ˍ

Santiago-Vicente Y, Castillejos-López MJ, Carmona-Aparicio L, Coballase-Urrutia E, Velasco-Hidalgo L, Niembro Zúñiga AM, Zapata-Tarrés M, Espíndola LMT.
Immunotherapy for Pediatric Gliomas: CAR T Cells Against B7H3: A Review of the Literature.
CNS Neurol Disord Drug Targets. 2023 Apr 6. doi: 10.2174/1871527322666230406094257. PMID: 37038673. Review˰ ˍ

Williamson D, Schwalbe EC, Bailey S, Clifford SC.
Timing is everything: A connection between medulloblastoma prognosis and fetal cerebellar development.
Neuropathol Appl Neurobiol. 2023 Apr 6:e12903. doi: 10.1111/nan.12903. PMID: 37021628. Review˰ ˍ

Gould A, Gonzales VAA, Dmello CC, Saganty R, Lukas RV, Zhang DY, Heimberger AB, Canney M, Carpentier A, Desseaux C, Bouchoux G, Stupp R, Sonabend AM.
Advances in Blood-Brain Barrier Disruption to Facilitate Drug Delivery for Infiltrative Gliomas.
Adv Oncol. 2023 Apr 7;3(1):77-86. doi: 10.1016/j.yao.2023.01.017. PMID: 37860079. Review.


Castillo SP, Galvez-Cancino F, Liu J, Pollard SM, Quezada SA, Yuan Y.
The tumour ecology of quiescence: niches across scales of complexity.
Semin Cancer Biol. 2023 Apr 8:S1044-579X(23)00062-7. doi: 10.1016/j.semcancer.2023.04.004. PMID: 37037400. Review˰ ˍ

Moreira DC, Lam CG, Bhakta N, Boop FA, Chiang J, Merchant TE, Rodriguez-Galindo C, Gajjar A, Qaddoumi I.
Tackling Pediatric Low-Grade Gliomas: A Global Perspective.
JCO Glob Oncol. 2023 Apr;9:e2300017. doi: 10.1200/GO.23.00017. PMID: 37043711. Commentary. ˍ

Marei HE, Hasan A, Pozzoli G, Cenciarelli C.
Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired.
Cancer Cell Int. 2023 Apr 10;23(1):64. doi: 10.1186/s12935-023-02902-0. PMID: 37038154. Review. ˍ

Thoidingjam S, Sriramulu S, Freytag S, Brown SL, Kim JH, Chetty IJ, Siddiqui F, Movsas B, Nyati S.
Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health.
Transl Med Commun. 2023 Apr 10;8(1):11. doi: 10.1186/s41231-023-00144-w. PMID: 37065938. Review. ˍ

Eatmann AI, Hamouda E, Hamouda H, Farouk HK, Jobran AWM, Omar AA, Madeeh AK, Al-Dardery NM, Elnoamany S, Abd-Elnasser EG, Koraiem AM, Ahmed AA, Abouzid M, Karaźniewicz-Łada M.
Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview.
Metabolites. 2023 Apr 11;13(4):543. doi: 10.3390/metabo13040543. PMID: 37110201. Review. ˍ

Girotto AL, Gago G, Paglioli Ferreira M.
Remote hemorrhagic complications of glioma surgery: Systematic review of the literature and report of a case of distant wounded glioma syndrome, a rare neurosurgical complication.
World Neurosurg. 2023 Apr 11:S1878-8750(23)00487-4. doi: 10.1016/j.wneu.2023.04.013. PMID: 37054950. Case report, Review˰ ˍ

Gupta T, Sahoo RK, Singh H, Katke S, Chaurasiya A, Gupta U.
Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities.
AAPS PharmSciTech. 2023 Apr 11;24(4):102. doi: 10.1208/s12249-023-02555-2. PMID: 37041350. Review˰ ˍ

Lorrey SJ, Waibl Polania J, Wachsmuth LP, Hoyt-Miggelbrink A, Tritz ZP, Edwards R, Wolf DM, Johnson AJ, Fecci PE, Ayasoufi K.
Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilege.
Neurooncol Adv. 2023 Apr 11;5(1):vdad035. doi: 10.1093/noajnl/vdad035. PMID: 37207119. Review. ˍ

Park CK, Chang JH.
Korean Brain Tumor Society (KBTS) Consensus Review for the Practical Recommendations on Glioma Management in Korea.
J Korean Neurosurg Soc. 2023 Apr 11. doi: 10.3340/jkns.2023.0046. PMID: 37042171. Guidelines. ˍ

Jovanovich N, Habib A, Head J, Hameed F, Agnihotri S, Zinn PO.
Pediatric diffuse midline glioma: Understanding the mechanisms and assessing the next generation of personalized therapeutics.
Neurooncol Adv. 2023 Apr 12;5(1):vdad040. doi: 10.1093/noajnl/vdad040. PMID: 37152806. Review. ˍ

Niyazi M, Andratschke N, Bendszus M, Chalmers AJ, Erridge SC, Galldiks N, Lagerwaard FJ, Navarria P, Munck Af Rosenschöld P, Ricardi U, van den Bent MJ, Weller M, Belka C, Minniti G.
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma.
Radiother Oncol. 2023 Apr 12:109663. doi: 10.1016/j.radonc.2023.109663. PMID: 37059335. Guidelines. ˍ


Zhao B, Wu J, Li H, Wang Y, Wang Y, Xing H, Wang Y, Ma W.
Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma.
Cell Commun Signal. 2023 Apr 12;21(1):74. doi: 10.1186/s12964-023-01098-0. PMID: 37046332. Review. ˍ

Galldiks N, Lohmann P, Fink GR, Langen KJ.
Amino Acid PET in Neurooncology.
J Nucl Med. 2023 Apr 13:264859. doi: 10.2967/jnumed.122.264859. PMID: 37055222. Continuing education. ˍ

Gállego Pérez-Larraya J, García-Moure M, Alonso MM.
Oncolytic virotherapy for the treatment of pediatric brainstem gliomas.
Rev Neurol (Paris). 2023 Apr 13:S0035-3787(23)00897-4. doi: 10.1016/j.neurol.2023.03.016. PMID: 37061388. Review˰ ˍ

Jellema PEJ, Wijnen JP, De Luca A, Mutsaerts HJMM, Obdeijn IV, van Baarsen KM, Lequin MH, Hoving EW.
Advanced intraoperative MRI in pediatric brain tumor surgery.
Front Physiol. 2023 Apr 13;14:1098959. doi: 10.3389/fphys.2023.1098959. PMID: 37123260. Review. ˍ


Sendy F, Arrighi M, Berton Q, Mourinet S, Screnci M, Gallot D, Coll G.
Diagnosis of medulloblastoma in pregnant women: to continue with the pregnancy or not? A case report and literature review.
Neurochirurgie. 2023 Apr 13:101443. doi: 10.1016/j.neuchi.2023.101443. PMID: 37061180. Case report, Review˰ ˍ

Ahmed MH, Canney M, Carpentier A, Idbaih A.
Overcoming the blood brain barrier in glioblastoma: Status and future perspective.
Rev Neurol (Paris). 2023 Apr 14:S0035-3787(23)00895-0. doi: 10.1016/j.neurol.2023.03.013. PMID: 37062676. Review˰ ˍ

Trinder SM, McKay C, Power P, Topp M, Chan B, Valvi S, McCowage G, Govender D, Kirby M, Ziegler DS, Manoharan N, Hassall T, Kellie S, Heath J, Alvaro F, Wood P, Laughton S, Tsui K, Dodgshun A, Eisenstat DD, Endersby R, Luen SJ, Koh ES, Sim HW, Kong B, Gottardo NG, Whittle JR, Khuong-Quang DA, Hansford JR.
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience.
Front Oncol. 2023 Apr 14;13:1154246. doi: 10.3389/fonc.2023.1154246. PMID: 37124503. Review. ˍ

Zeng YF, Wei XY, Guo QH, Chen SY, Deng S, Liu ZZ, Gong ZC, Zeng WJ.
The efficacy and safety of anti-PD-1/PD-L1 in treatment of glioma: a single-arm meta-analysis.
Front Immunol. 2023 Apr 14;14:1168244. doi: 10.3389/fimmu.2023.1168244. PMID: 37122727. Meta-analysis. ˍ

Alshiekh Nasany R, de la Fuente MI.
Therapies for IDH-Mutant Gliomas.
Curr Neurol Neurosci Rep. 2023 Apr 15. doi: 10.1007/s11910-023-01265-3. PMID: 37060388. Review. ˍ